Summary A cohort study was conducted to investigate the mortality of individuals employed by biological research institutes in the UK. The inclusion criteria were met by 12703 individuals, of whom 95% were traced (11 502 alive, 395 deaths, 246 embarkations). All-cause mortality was significantly reduced in men (standardised) mortality ratio (SMR) 55 and women (SMR 52). Mortality was also significantly reduced for circulatory and respiratory diseases, and overall there was low mortality from malignant neoplasms. SMRs exceeded 100, but were not statistically significant, for infective and parasitic diseases. There were no statistically significant raised SMRs for any cancer site. Workers were categorised as ever worked in a laboratory (laboratory workers) and never worked in a laboratory (non-laboratory workers). The all-cause SMR was significantly reduced in both groups, as was mortality from circulatory and respiratory diseases. The SMR for malignant neoplams was also significantly reduced in laboratory workers. On the basis of follow-up to 31 December 1994, there is no evidence of any overall increased risk of mortality in biological research laboratory workers. However, the power of the analysis is limited by the young age of many cohort members and short duration of follow-up. Follow-up is continuing and the data will be reanalysed once more deaths have accumulated.
Work in molecular biology entails exposure to a range of hazards including ionising radiation, chemicals (some of which are mutagenic and carcinogenic in animals and humans) and infectious agents. During the 1980s a cluster of rare cancers occurred among staff at the Institut Pasteur in Paris (Cordier, 1990) . All of the cases involved individuals who were less than 50 years old and had been engaged in biomedical research. This led the International Agency for Research on Cancer (IARC) at the request of a group of experts to initiate an international collaborative retrospective cohort study of biological research workers looking particularly at their risk of cancer (Sasco, 1992) . This paper reports on the initial findings on mortality in the British component of the IARC study.
Materials and methods
The cohort was recruited from 24 institutes that had carried out biological, biomedical or agronomic research as their main activity, had operated for at least 10 years, and were funded by national Research Councils or by charities (Table  I ). The director of each institute was first approached and full discussion took place with staff representatives at each institute. All of the institutes had engaged in molecular biology, except institute 12, which was administered through institute 3 and was included to boost the number of unexposed subjects for internal comparisons. One further institute was invited to take part in the study but had to be excluded because more than 10% of current staff refused permission for their personnel records to be accessed. The main activities carried out at the participating institutes are listed in Table I workers and students were excluded.
Subjects were identified from personnel records and their occupational histories while at the relevant institute were abstracted. The completeness of the information obtained was checked by review of payroll records, staff lists and annual reports and where this exercise identified people not listed in personnel files, further checks were made. In most cases the names of missing individuals appeared in only one or two consecutive annual reports, suggesting that they had worked for a relatively short time at that institute. When subjects had worked at more than one of the participating institutes, the records from each institute were collated. The occupations recorded in personnel files were assigned to two broad categories according to whether or not they entailed work for more that 1 h per week in a laboratory. This classification was again carried out with help from heads of laboratories and senior staff. Staff working for more than 1 h per week in a laboratory were designated as 'laboratory workers' and the others as 'non-laboratory workers'.
The cohort was followed-up through the National Health Service (NHS) Central Register, and death certificates were obtained for subjects who had died up to 31 December 1994 with the underlying cause of death coded to the ninth revision of the International Classification of Diseases (1CD-9). Where subjects were difficult to trace at the NHS Central Register, additional information was sought from Department of Social Security records and this sometimes enabled tracing to be completed.
The mortality of cohort members was compared with that of the national population (England and Wales or Scotland according to the location of the institute) by the personyears method, with age and calendar period stratified in 5 year bands. Confidence intervals (CIs) for standardised mortality ratios (SMRs) were based on the Poisson distribution (Gardner et al., 1989) .
In the analysis of mortality of laboratory workers and non-laboratory workers, some individuals had experience in both types of work. If the job entailing laboratory work preceded the non-laboratory job, then all the person-years were attributed to the laboratory work group. If the nonlaboratory work preceded the laboratory work, then personyears in the non-laboratory post counted as non-laboratory, while the succeeding person-years accrued to the laboratory workers category. Thus, once an individual began work in the laboratory all subsequent years accrued to that category. (Table II) . There was a small excess of deaths from infective and parasitic diseases (SMR 158, six deaths), but this was not statistically significant. Table III shows mortality from specific types of cancer. SMRs were elevated for cutaneous melanoma (four deaths), other skin cancers (two deaths), and cancers of the uterine body (two deaths), thyroid (two deaths), myeloma (four deaths) and leukaemia (seven deaths). However, none of these-increases was statistically significant. As in other studies of chemists and laboratory workers, aSecondary malignant neoplasms of other specified sites (1 male, 1 female); Malignant neoplasm without specification of site (8 males, 5 females).
0, observed number of deaths; E, expected number of deaths; SMR, standardised mortality ratio; NHL, non-Hodgkin's lymphoma. 115 overall mortality in our cohort was well below that in the national population (Li et al., 1969; Hoar and Pell, 1981; Cordier, 1990; Belli et al., 1992; Hunter et al., 1993) . In addition to the normal 'healthy worker effect' from selective exclusion of chronically disabled people from employment, it is likely that the study population had an unusually healthy lifestyle. For example, the deficit of deaths from lung cancer (SMR 62) suggests a low prevalence of smoking. If anything, cohort members who had worked in laboratories had lower mortality than those who had not (Table IV) .
The shortfall in deaths from lung cancer contnrbuted to low mortality from cancer. As would be expected, a few specific cancers occurred in excess, although not to the point of statistical significance. In general, these were not tumours that have been linked with laboratory work previously. The cluster of cancers at the Institut Pasteur which stimulated our investigation comprised tumours of the brain, pancreas and bone (Cordier, 1990) . Subsequently, a cohort study at the Instituto Superiore di Sanita in Rome found excesses of brain, pancreatic and lymphohaematopoietic cancers (Beffi et al., 1992) . In the UK, analysis of cancer registrations among chemists, physical or biological scientists and laboratory assistants showed a small excess of brain and nervous system cancers, but was otherwise unremarkable (Carpenter et al., 1991) . Two studies of people working in agricultural research have indicated increased risks of lymphoma and cancer of the colon, and of brain, bladder and heamatopoietic cancer (Dosemeci et al., 1992; Daly et al., 1994) . In our study elevated mortality was observed from malignant melanoma, other skin cancer, cancers of the uterine body and thyroid, multiple myeloma and leukaemia, but none of these was statistically significant. Among the subset of subjects who had worked for more than 1 h per week in a laboratory, deaths from lymphohaematopoietic cancer were close to expectation. Examination of the occupational histories of the two subjects who died of thyroid cancer, revealed that one was categorised as a laboratory worker and the other had never worked in a laboratory. There was nothing in the available records to suggest an occupational cause for their illness.
Six members of the cohort died from infective or parasitic disease as compared with 3.8 expected. Four of these deaths were known definitely to be in laboratory workers (2.4 expected), of which two were from viral hepatitis, and occurred in men who had worked in laboratories where viruses were handled. We do not know whether their jobs entailed contact with hepatitis viruses.
Overall, the findings of this study are reassuring, with no evidence of any important increase in mortality from cancer. However, the power of the analysis is limited by the young age of many cohort members and relatively short duration of follow-up. Furthermore, the effects of a hazard may have been obscured if only a small proportion of subjects were exposed to it. The patterns of exposure in the cohort are complex and will be described in a separate paper. At this stage, however, there are too few deaths to warrant a detailed analysis by exposure. Such analysis should become possible with continued follow-up and when findings are combined with those from the other parallel studies being coordinated by IARC.
